Teadusrahastus tõuseb järgmisel aastal ühe protsendini SKP-st
Uued Uudised
(FILES) In this file photo taken on February 10, 2020 Doctor Paul McKay, who is working on an vaccine for the 2019-nCoV strain of the novel coronavirus poses for a photograph using a microscope to look at bacteria containing coronavirus DNA fragments, in a research lab at Imperial College School of Medicine (ICSM) in London on February 10, 2020. - The British government is touting the country as a global leader in the big-money investment race to find a vaccine for COVID-19 the illness caused by infection with the novel coronavirus. Ministers claim two studies in particular -- at Oxford University and Imperial College London -- are "frontrunners" in the international effort. Oxford has now received more than £85 million ($104 million, 95 million euros), and Imperial nearly £43 million, in British state funding. (Photo by Tolga AKMEN / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / HARWELL SCIENCE AND INNOVATION CAMPUS " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS -- TO GO WITH AFP STORY BY JOE JACKSON / TO GO WITH AFP STORY BY JOE JACKSON
Valitsus tõstab teadus- ja arendustegevuse rahastamise taseme järgmisel aastal ühe protsendini sisemajanduse koguproduktist (SKP).
Rahandusminister Martin Helme täpsustas teisipäevasel pressikonverentsil, et teadusele ja arendusele suunatav summa suureneb järgmisel aastal 56 miljoni euro võrra 280 miljoni euroni.
Tänavu on teaduse rahastamise osakaal riigieelarves 0,75 protsenti SKP-st.
Valitsus kinnitas teisipäevasel istungil 2021. aasta riigieelarve ning esitab riigieelarve eelnõu riigikogule kolmapäeval. Eelarve kulutuste maht on kokku ligikaudu 13 miljardit eurot ning tulude maht üle 11 miljardi euro.
